Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Journal of the Egyptian Society of Parasitology. 2005; 35 (1): 49-59
in English | IMEMR | ID: emr-72310

ABSTRACT

In a survey carried out during summer and autumn of 2004, for snails of medical importance, nine species were recovered. They were Biomphalaria alexandrina, B. glabrata, B. pfeifferi, Bulinus truncatus, B. forskalii, Lymnaea natalensis, Bellamya [=Vivipara] unicolor, Physa acuta and Hydrobia mesaensis. Parasitological examination revealed that B. alexandrina, B. glabrata and L. natalensis harboured immature stages of their concerned trematode parasites. Moreover, P. acuta harboured the immature stage of the nematode parasite Parastrongylus cantonensis


Subject(s)
Data Collection , Medicaid , Fresh Water , Snails/parasitology , Biomphalaria , Bulinus , Lymnaea
2.
Journal of the Egyptian Society of Parasitology. 2004; 34 (2): 423-46
in English | IMEMR | ID: emr-66746

ABSTRACT

A field survey was done in Ezbet El-Bakly [Tamyia Center], El-Fayoum Governorate to determine the magnitude of Schistosomiasis haematobium and mansoni and to evaluate the efficacy of Mirazid [the oleo-resin extract from myrrh of Commiphora molmol tree, family: Burseraceae] in the treatment of both types of schistosomiasis. Among the 1019 individuals parasitologically examined, the prevalence of S. haematobium and S. mansoni was 4.2% and 2.4%, respectively, and the geometric mean egg count [GMEC] was 33.2 eggs/10 ml urine and 113.3 eggs/g stools. It was concluded that mirazid proved to be safe and very effective in the treatment of S. Haematobium and S. Mansoni infections under field conditions


Subject(s)
Humans , Male , Female , Plant Extracts , Urine , Feces , Treatment Outcome , Schistosomiasis mansoni/drug therapy , Schistosoma haematobium/drug therapy
3.
Journal of the Egyptian Society of Parasitology. 2004; 34 (3): 807-18
in English | IMEMR | ID: emr-66776

ABSTRACT

A field survey was done in Ezbet EI-Bakly, El-Fayoum Governorate, Egypt to assess the efficacy and safety of mirazid in the treatment of human fascioliasis. Among 1019 individuals examined for parasitosis, the prevalence of fascioliasis was 1.7% and the geometric mean egg count [GMEC] was 33.2 eggs/g stools. About 23.5% of the fascioliasis patients were asymptomatic. It was concluded that mirazid [or myrrh extract of Commiphora molmol] is safe and effective in the treatment of human fascioliasis under the field conditions


Subject(s)
Humans , Male , Female , Plant Extracts , Feces , Treatment Outcome , Follow-Up Studies
SELECTION OF CITATIONS
SEARCH DETAIL